These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 29432499)

  • 21. Sponsorship, authorship, and accountability.
    Davidoff F; DeAngelis CD; Drazen JM; Nicholls MG; Hoey J; Højgaard L; Horton R; Kotzin S; Nylenna M; Overbeke AJ; Sox HC; Van Der Weyden MB; Wilkes MS
    N Engl J Med; 2001 Sep; 345(11):825-6; discussion 826-7. PubMed ID: 11556304
    [No Abstract]   [Full Text] [Related]  

  • 22. Data monitoring boards in the pharmaceutical industry.
    Herson J
    Stat Med; 1993 Mar; 12(5-6):555-61; discussion 563. PubMed ID: 8493431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sponsorship, authorship and accountability.
    Loder E
    N Z Med J; 2001 Dec; 114(1145):559. PubMed ID: 11833961
    [No Abstract]   [Full Text] [Related]  

  • 24. Influence of drug company authorship and sponsorship on drug trial outcomes.
    Tungaraza T; Poole R
    Br J Psychiatry; 2007 Jul; 191():82-3. PubMed ID: 17602130
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sponsorship, authorship, and accountability.
    Davidoff F; Deangelis CD; Drazen JM; Nicholls MG; Hoey J; Hojgaard L; Horton R; Kotzin S; Nylenna M; Overbeke JP; Sox HC; Van der Weyden MB; Wilkes MS;
    Ugeskr Laeger; 2001 Sep; 163(37):4983-5. PubMed ID: 11573367
    [No Abstract]   [Full Text] [Related]  

  • 26. Gag clauses in clinical-trial agreements.
    Steinbrook R
    N Engl J Med; 2005 May; 352(21):2160-2. PubMed ID: 15917381
    [No Abstract]   [Full Text] [Related]  

  • 27. Sponsorship, authorship and accountability.
    Davidoff F; DeAngelis CD; Drazen JM; Nicholls MG; Hoey J; Højgaard L; Horton R; Kotzin S; Nylenna M; Overbeke JP; Sox HC; Van der Weyden MB; Wilkes MS
    Lakartidningen; 2001 Oct; 98(43):4694-6. PubMed ID: 11715244
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical-trial agreements between medical schools and industry.
    Novak JW
    N Engl J Med; 2003 Jan; 348(5):476-8; author reply 476-8. PubMed ID: 12556555
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical investigators and the pharmaceutical industry.
    Bellin E
    N Engl J Med; 2000 Aug; 343(7):511. PubMed ID: 10950676
    [No Abstract]   [Full Text] [Related]  

  • 30. Good practice for publishing the results of clinical trials.
    Wager E
    J Br Menopause Soc; 2005 Sep; 11(3):109-11. PubMed ID: 16157002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between drug company funding and outcomes of clinical psychiatric research.
    Kelly RE; Cohen LJ; Semple RJ; Bialer P; Lau A; Bodenheimer A; Neustadter E; Barenboim A; Galynker II
    Psychol Med; 2006 Nov; 36(11):1647-56. PubMed ID: 16893480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sponsorship, authorship and accountability.
    Davidoff F; DeAngelis CD; Drazen JM; Nicholls MG; Hoey J; Højgaard L; Horton R; Kotzin S; Nylenna M; Overbeke AJ; Sox HC; Van Der Weyden MB; Wilkes MS;
    CMAJ; 2001 Sep; 165(6):786-8. PubMed ID: 11584570
    [No Abstract]   [Full Text] [Related]  

  • 33. NIH mulls rules for validating key results.
    Wadman M
    Nature; 2013 Aug; 500(7460):14-6. PubMed ID: 23903729
    [No Abstract]   [Full Text] [Related]  

  • 34. The NIH, research institutions and industry: working together on a shared goal.
    Omary MB
    Gastroenterology; 2007 May; 132(5):1647-50. PubMed ID: 17484859
    [No Abstract]   [Full Text] [Related]  

  • 35. Research misconduct identified by the US Food and Drug Administration: out of sight, out of mind, out of the peer-reviewed literature.
    Seife C
    JAMA Intern Med; 2015 Apr; 175(4):567-77. PubMed ID: 25664866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Industry-sponsored pharmaceutical trials and research ethics boards: are they cloaked in too much secrecy?
    Ferris LE
    CMAJ; 2002 May; 166(10):1279-80. PubMed ID: 12041844
    [No Abstract]   [Full Text] [Related]  

  • 37. Introduction: Institutional corruption and the pharmaceutical policy.
    Rodwin MA
    J Law Med Ethics; 2013; 41(3):544-52. PubMed ID: 24088143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Commentary: But what should journals actually do to keep industry sponsored research unbiased?
    Del Mar C
    BMJ; 2010 Oct; 341():c5406. PubMed ID: 20940215
    [No Abstract]   [Full Text] [Related]  

  • 39. The role of pharmaceutical companies in sponsored research.
    Novack GD
    Ophthalmology; 2007 Jun; 114(6):1037-8. PubMed ID: 17544773
    [No Abstract]   [Full Text] [Related]  

  • 40. Minimizing bias in industry-sponsored outcomes research.
    Freeman RA
    Med Interface; 1994 Apr; 7(4):130-4. PubMed ID: 10133357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.